Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Omicron Variant SARS-CoV-2 Infection in People with a Prior SARS-CoV-2 Infection
Margaret L. Lind, Alexander J. Robertson, Julio Silva, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17

Showing 17 citing articles:

Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
Niklas Bobrovitz, Harriet Ware, Xiaomeng Ma, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 5, pp. 556-567
Open Access | Times Cited: 471
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 45-55
Open Access | Times Cited: 84
Protection against Omicron from Vaccination and Previous Infection in a Prison System
Elizabeth T. Chin, David Leidner, Lauren Lamson, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 19, pp. 1770-1782
Open Access | Times Cited: 56
A Systematic Review and Meta-Analysis on the Real-World Effectiveness of COVID-19 Vaccines against Infection, Symptomatic and Severe COVID-19 Disease Caused by the Omicron Variant (B.1.1.529)
Hassen Mohammed, Dan Duy Pham-Tran, Zi Yi Michelle Yeoh, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 224-224
Open Access | Times Cited: 34
Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 29
Protective effectiveness of prior SARS-CoV-2 infection and hybrid immunity against Omicron infection and severe disease: a systematic review and meta-regression
Niklas Bobrovitz, Harriet Ware, Xiaomeng Ma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 17
Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort
Ida Laake, Siri N. Skodvin, Kristine Blix, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 11, pp. 1924-1933
Open Access | Times Cited: 16
Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection—Final Update of a Living, Rapid Review
Haley K Holmer, Katherine Mackey, Celia Fiordalisi, et al.
Annals of Internal Medicine (2022) Vol. 176, Iss. 1, pp. 85-91
Open Access | Times Cited: 15
Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
Sharon Walmsley, Majid Nabipoor, Freda Qi, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 564-564
Open Access | Times Cited: 2
Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infection
Elizabeth T. Chin, David Leidner, Lauren Lamson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 11
Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination
Sara Carazo, Danuta M. Skowronski, Marc Brisson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Serial cross-sectional estimation of vaccine and infection-induced SARS-CoV-2 sero-prevalence in children and adults, British Columbia, Canada: March 2020 to August 2022
Danuta M. Skowronski, Samantha E Kaweski, Michael A. Irvine, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Previous Infection and Effectiveness of COVID-19 Vaccination in Middle- and High-School Students
Olivia Almendares, Jasmine Ruffin, Abigail Collingwood, et al.
PEDIATRICS (2023) Vol. 152, Iss. 6
Open Access | Times Cited: 2
Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study
Sabir Meah, Xu Shi, Lars G. Fritsche, et al.
Science Advances (2023) Vol. 9, Iss. 51
Open Access | Times Cited: 2
Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection
Huiling Zheng, Shenggen Wu, Chen Wu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access
Effectiveness of SARS-CoV-2 Vaccines against Omicron Infection and Severe Events: A Systematic Review and Meta-Analysis of Test-Negative Design Studies
Shangchen Song, Zachary J. Madewell, Ming‐Jin Liu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Design and Analysis Heterogeneity in Observational Studies of COVID-19 Booster Effectiveness: A Review and Case Study
Sabir Meah, Xu Shi, Lars G. Fritsche, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top